Solana Company

NASDAQ:HSDT

Medical - Devices

Healthcare
$1.63 +0.63%

+$0.01 today

Market cap
$95.17M
Beta
1.03
P/E (TTM)
-0.9
EPS (TTM)
-$1.78
52W Low $1.19High $25.50

Volume 0.23M

Average 0.38M

HSDT Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Solana CompanyNASDAQ: HSDT

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares growth accelerates

Q1 FY2026 weighted avg shares of 76.74M shares rose 2731.8% year over year, ahead of the +788.1% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 248.0% from the prior quarter. Over 3 fiscal years it compounded at +244.4% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +2731.8% holds above the trailing-twelve-month pace of +788.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
76.74M+248.0% QoQ
Last fiscal yearDec 2025
22.05M+713.6% YoY
LTMMar 2026
25.93M+788.1% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+2731.8%——
1 year+713.6%——
3-year CAGR+244.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
22.05M USD
Year-over-year change
+713.6%
4-year CAGR
+287.0%

Weighted Avg Shares vs competitors

How HSDT compares with its peers on the latest reported figures

  • HSDT's LTM Mar 2026 weighted avg shares of 25.93M shares is the 7th highest of the 11 companies compared; the peer median is 29.38M shares.
  • Its year-over-year change of +788.1% is the highest of 11, against a peer median of +14.1%.
  • Over three fiscal years its annual growth of +244.4% compares with a peer median of +8.9%.
HSDT Competitors Peer median
Weighted Avg Shares for HSDT and competitors
Company Period LTM YoY 3-year CAGR
NNOXNano-X Imaging Ltd.LTM Dec 202564.81M +10.5%+7.4%
CATXPerspective Therapeutics, Inc.LTM Mar 202654.95M -21.6%+10.4%
QTRXQuanterix CorporationLTM Mar 202644.68M +16.0%+4.9%
TLSITriSalus Life Sciences, Inc.LTM Mar 202643.59M +65.4%+18.4%
PROFProfound Medical Corp.LTM Mar 202631.8M +21.2%+13.2%
INGNInogen, Inc.LTM Mar 202626.97M +12.1%+5.9%
HSDTSolana CompanyLTM Mar 202625.93M +788.1%+244.4%
INFUInfuSystem Holdings, Inc.LTM Mar 202620.52M -3.4%+0.0%
OMOutset Medical, Inc.LTM Mar 202617.93M +423.3%+68.0%
SNWVSANUWAVE Health, Inc.LTM Mar 20268.57M +83.3%+80.1%
ELMDElectromed, Inc.LTM Mar 20268.28M -4.4%-0.5%
Peer median (excluding HSDT) 29.38M+14.1%+8.9%

Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue522K787K644K520K6.02M
Cost of Revenue298K463K583K582K500K
Gross Profit224K324K61K(62K)5.52M
Gross Margin42.9%41.2%9.5%-11.9%91.7%
Research & Development5.99M4.26M2.94M3.66M3.51M
Selling, General & Admin12.18M10.64M9.27M10.12M23.13M
Operating Expenses18.37M15.84M12.49M13.84M26.64M
Depreciation & Amortization312K255K162K60K680K
EBITDA(17.82M)(14.5M)(12.11M)(13.8M)(39.58M)
EBITDA Margin-3413.8%-1842.9%-1880.0%-2654.4%-657.7%
Operating Income(18.14M)(15.52M)(12.43M)(13.9M)(21.12M)
Operating Margin-3475.5%-1971.5%-1929.8%-2673.7%-351.0%
Interest Income00257K00
Interest Expense0834K017K635K
Other Income / Expenses10K1.44M3.58M2.16M(19.77M)
Income Before Tax(18.13M)(14.07M)(8.85M)(11.74M)(40.89M)
Pre-Tax Margin-3473.6%-1788.1%-1374.2%-2258.1%-679.6%
Income Tax Expense00000
Net Income(18.13M)(14.07M)(8.85M)(11.74M)(40.89M)
Net Margin-3473.6%-1788.1%-1374.2%-2258.1%-679.6%
EPS (Basic)(184.51)(26.06)(7.28)(4.33)(1.85)
EPS (Diluted)(184.51)(26.06)(7.28)(4.33)(1.85)
Weighted Avg Shares98.27K539.89K1.22M2.71M22.05M
Weighted Avg Shares (Diluted)98.27K539.89K1.22M2.71M22.05M

Solana Company

NASDAQ:HSDT

Intrinsic Alpha fair value

Locked

Current Price

$1.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.